ResMed's CEO Discusses Q3 2012 Results - Earnings Call Transcript
ResMed (RMD)
Q3 2012 Earnings Call
April 26, 2012 4:30 pm ET
Executives
Peter C. Farrell - Founder, Executive Chairman, Chief Executive Officer and PresidentBrett A. Sandercock - Chief Financial Officer and Principal Accounting OfficerUnknown Executive - Michael J. Farrell - President of Americas OperationsGeoff Neilson - President of Respiratory Care Strategic Business UnitRobert Douglas - Chief Operating OfficerAnalystsDavid Low - Deutsche Bank AG, Research DivisionBen Andrew - William Blair & Company L.L.C., Research DivisionMatthew Prior - BofA Merrill Lynch, Research DivisionJoanne K. Wuensch - BMO Capital Markets U.S.David C. Clair - Piper Jaffray Companies, Research DivisionSaul Hadassin - Crédit Suisse AG, Research DivisionDavid Stanton - Nomura Securities Co. Ltd., Research DivisionSteven D. Wheen - JP Morgan Chase & Co, Research DivisionBen C. Haynor - Feltl and Company, Inc., Research DivisionMichael Matson - Mizuho Securities USA Inc., Research DivisionPresentationOperatorPrevious Statements by RMD
» ResMed's CEO Discusses F2Q12 Results - Earnings Call Transcript
» ResMed's CEO Discusses F1Q 2012 Results - Earnings Call Transcript
» ResMed's CEO Discusses Q4 2011 Results - Earnings Call Transcript
Select the service that is right for you!
COMPARE ALL SERVICESAction Alerts PLUS
TRY IT FREEJim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
Product Features:
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Dividend Stock Advisor
TRY IT FREENew! $49.95/yr
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Product Features:
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREEDavid Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Product Features:
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
- Weekly roundups
Real Money
TRY IT FREE24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.
Product Features:
- Jim Cramer + 20 Wall Street pros
- Intraday commentary & news
- Real-time trading forum
- Actionable trade ideas
Real Money Pro
TRY IT FREEAll of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Product Features:
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Options Profits
TRY IT FREEOur options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
Product Features:
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV
